Key result
The feline calicivirus detection rate in Shandong Province was 70.69%, and the FCV023 strain demonstrated strong cross-neutralizing activity, indicating its potential as a vaccine candidate.
Why the study?
Significant differences among feline calicivirus strains limit vaccine efficacy, warranting an understanding of regional prevalence and characteristics to facilitate novel vaccine development.
The FCV023 strain exhibits high pathogenicity and elicits broad neutralizing antibodies, making it a promising candidate for feline calicivirus vaccine development.
Answers are grounded in this paper and cite their sources.
Supports FCV023 as a vaccine candidate in feline models; leaves open efficacy confirmation in prospective trials.
IMPORTANCE: The feline calicivirus (FCV) is globally prevalent with regional specificity in its distribution, but the significant differences among strains limit the efficacy of vaccines. Therefore, understanding the prevalence and biological characteristics of FCV holds immense significance in facilitating the development of novel vaccines and targeted pharmaceuticals. OBJECTIVE: This study aimed to understand the epidemiological status of the FCV in the Shandong region and identify candidate strains for vaccine development. METHODS: In this study, 41 FCV strains were obtained from Shandong province in China. Phylogenetic analysis was conducted based on the VP1. The FCV023 strain was selected for pathogenicity and immunogenicity analysis. RESULTS: neutralization assay showed that FCV023 positive serum could produce a neutralizing titer against FCV isolates distributed in different branches of phylogenetic trees. CONCLUSIONS AND RELEVANCE: The FCV detection rate in Shandong Province was 70.69%, significantly higher than in other regions. Phylogenetic analysis suggested that FCV strains exhibit characteristic regional prevalence in Shandong Province. As a representative strain, FCV023 infections can cause typical upper respiratory symptoms in cats. The preliminarily screened FCV023 immune serum showed good neutralizing activity and can be considered a candidate strain for vaccine development.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2025) studied Feline calicivirus infection (n=58). FCV023 inactivated vaccine vs. PBS or commercial trivalent-inactivated vaccine was evaluated on Neutralizing antibody titer. The feline calicivirus detection rate in Shandong Province was 70.69%, and the FCV023 strain demonstrated strong cross-neutralizing activity, indicating its potential as a vaccine candidate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: